Advertisement
Advertisement
GMED
GLOBUS MEDICAL INC
86.32
USDSponsored
+0.17
+0.20%
Aug 11, 15:44 UTC -4
Open
GMED Earnings Reports
Positive Surprise Ratio
GMED beat 29 of 43 last estimates.
67%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$808.09M
/$1.21
Implied change from Q2 26 (Revenue/ EPS)
+2.34%
/-9.70%
Implied change from Q3 25 (Revenue/ EPS)
+5.08%
/+2.54%
GLOBUS MEDICAL INC earnings per share and revenue
On Aug 06, 2026, GMED reported earnings of 1.34 USD per share (EPS) for Q2 26, beating the estimate of 1.12 USD, resulting in a 19.50% surprise. Revenue reached 789.61 million, compared to an expected 798.50 million, with a -1.11% difference. The market reacted with a +1.57% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of 1.21 USD, with revenue projected to reach 808.09 million USD, implying an decrease of -9.70% EPS, and increase of 2.34% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.36
Actual
-$0.36
Surprise
+1.96%
Tandem Diabetes Care, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.31
Surprise
+4.94%
Artivion, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.01
Actual
-$0.28
Surprise
-2,845.10%
Tactile Systems Technology, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.14
Actual
$0.34
Surprise
+131.45%
Mesa Laboratories Inc
Report Date
Aug 10, 2026 For Q1 27
Estimate
$0.03
Actual
$2.61
Surprise
+8,429.41%
908 Devices Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.17
Actual
-$0.11
Surprise
+36.56%
Treace Medical Concepts, Inc. Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.30
Actual
-$0.24
Surprise
+21.05%
Neuronetics, Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.12
Actual
-$0.05
Surprise
+60.00%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.27
Surprise
-8.78%
Xtant Medical Holdings, Inc.
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.07
Surprise
-243.14%
FAQ
What were GLOBUS MEDICAL INC's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, GLOBUS MEDICAL INC reported EPS of $1.34, beating estimates by 19.5%, and revenue of $789.61M, -1.11% below expectations.
How did the market react to GLOBUS MEDICAL INC's Q2 2026 earnings?
The stock price moved up 1.57%, changed from $81.08 before the earnings release to $82.35 the day after.
When is GLOBUS MEDICAL INC expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for GLOBUS MEDICAL INC's next earnings report?
Based on --
analysts, GLOBUS MEDICAL INC is expected to report EPS of $1.21 and revenue of $808.09M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement